Banque Cantonale Vaudoise’s Nu Skin NUS Stock Holding History

Banque Cantonale Vaudoise’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,646	Closed	-$57K	–	856
2025 Q3	$57K	Buy	+4,646	New	+$48.8K	﹤0.01%	672

Other funds holding NUS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Banque Cantonale Vaudoise's NUS Position: Q4 2025 in Review

Banque Cantonale Vaudoise sold out of Nu Skin (NUS) in Q4 2025, closing a stake of 4,646 shares — an estimated $57K sold.

Banque Cantonale Vaudoise first reported a position in NUS in Q3 2025 and held it in 1 quarter. The position peaked at $57K in Q3 2025. 187 funds tracked by Wall St. Rank hold NUS as of Q4 2025.

Banque Cantonale Vaudoise reported no remaining Nu Skin position as of Q4 2025 after selling out during the quarter.
Banque Cantonale Vaudoise sold 4,646 Nu Skin shares in Q4 2025, an estimated $57K.
Banque Cantonale Vaudoise first reported a position in Nu Skin in Q3 2025 and held it in 1 quarter.
Banque Cantonale Vaudoise's Nu Skin position peaked at $57K in Q3 2025.
187 funds tracked by Wall St. Rank held Nu Skin as of Q4 2025.

Based on Banque Cantonale Vaudoise's 13F filing for Q4 2025, filed 6 Feb 2026.